Almost Family, Inc. is a provider of home healthcare services. The Company has two divisions: Home Health and Healthcare Innovations (HCI). The Home Health division consists of two segments: Visiting Nurse Services (VN or Visiting Nurse) and Personal Care Services (PC or Personal Care). The VN segment provides a range of Medicare-certified home health nursing services to patients in need of recuperative care, following a period of hospitalization or care in another type of inpatient facility. The PC segment provides services in patients' homes primarily on an as-needed, hourly basis. These services include personal care, medication management, meal preparation, caregiver respite and homemaking. The HCI segment includes its developmental activity outside of the home health business platform. HCI activities include technology, information, population health management, risk-sharing, enhanced patient engagement and informed clinical decision making.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Social services
Sub-IndustryHealth Care Services
SectorMedical
Current SymbolNASDAQ:AFAM
Previous Symbol
CUSIP02040910
Phone502-891-1000
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees17,100
Outstanding SharesN/A
Market Cap$0.00
OptionableOptionable
Almost Family (NASDAQ:AFAM) Frequently Asked Questions
What is Almost Family's stock symbol?
Almost Family trades on the NASDAQ under the ticker symbol "AFAM."
How were Almost Family's earnings last quarter?
Almost Family Inc (NASDAQ:AFAM) issued its quarterly earnings data on Monday, February, 26th. The company reported $0.58 earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of $0.58. The company had revenue of $200.62 million for the quarter, compared to the consensus estimate of $203.44 million. The firm's revenue was up 30.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.59 EPS. View Almost Family's Earnings History.
What price target have analysts set for AFAM?
3 Wall Street analysts have issued 12 month price targets for Almost Family's stock. Their predictions range from $56.00 to $65.00. On average, they expect Almost Family's share price to reach $60.00 in the next year. This suggests a possible upside of 7.1% from the stock's current price. View Analyst Price Targets for Almost Family.
What is the consensus analysts' recommendation for Almost Family?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Almost Family in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Almost Family.
Has Almost Family been receiving favorable news coverage?
News coverage about AFAM stock has been trending positive this week, according to InfoTrie. The research group rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Almost Family earned a media sentiment score of 2.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future.
Who are some of Almost Family's key competitors?
Some companies that are related to Almost Family include 22nd Century Group (XXII), 3D Signatures (DXD), 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abaxis (ABAX), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acasti Pharma (ACST), Acerus Pharmaceuticals (ASP), Acrux (ACR), Actinium Pharmaceuticals (ATNM), Activecare (ACAR) and Advanced Accelerator Application (AAAP).
Who are Almost Family's key executives?
Almost Family's management team includes the folowing people:
- William B. Yarmuth, Chairman of the Board, Chief Executive Officer (Age 64)
- C. Steven Guenthner, President, Principal Financial Officer (Age 56)
- Daniel J. Schwartz, Chief Operating Officer, Senior Vice President - Operations (Age 50)
- Rajneesh Kaushal, Senior Vice President and Chief Clinical Officer (Age 56)
- Patrick Todd Lyles, Senior Vice President - Administration (Age 55)
- Clifford S. Holtz, Director (Age 58)
- Henry M. Altman Jr., Independent Director (Age 80)
- Steven B. Bing, Independent Director (Age 70)
- Jonathan D. Goldberg, Independent Director (Age 65)
- Donald G. McClinton, Independent Director (Age 83)
How do I buy shares of Almost Family?
Shares of AFAM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Almost Family's stock price today?
One share of AFAM stock can currently be purchased for approximately $56.00.
What is Almost Family's official website?
How can I contact Almost Family?
Almost Family's mailing address is 9510 ORMSBY STATION ROAD SUITE 300, LOUISVILLE KY, 40223. The company can be reached via phone at 502-891-1000 or via email at [email protected]
MarketBeat Community Rating for Almost Family (NASDAQ AFAM)
MarketBeat's community ratings are surveys of what our community members think about Almost Family and other stocks. Vote "Outperform" if you believe AFAM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFAM will underperform the S&P 500 over the long term. You may vote once every thirty days.
